Experimental Pharmacology, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin-Buch, Germany.
J Pharm Sci. 2010 May;99(5):2423-33. doi: 10.1002/jps.22001.
The aim of this study was to investigate the effect of liposomal membrane properties on cellular uptake and transcytosis across a tight Madin-Darby canine kidney (MDCK) cell barrier in vitro. More than 25 small vesicles were prepared by lipid film hydration/extrusion to generate small unilamellar vesicles. The fluorescence marker calcein was encapsulated to mimic hydrophilic drug transport. Marker uptake by MDCK cells seems to be mediated by different mechanisms for the liposomes used. It was mainly depending on membrane fluidity and vesicle charge. Liposomes L2 with a positive charge (325 +/- 3 pmol/well) and vesicles L3 containing the helper lipid dioleylphosphatidylethanolamine (DOPE) in their membrane (216 +/- 42 pmol/well) were taken up to the most. Selected liposomes were tested for their transcytotic transport across a MDCK monolayer. Liposomes L4 containing equimolar DOPE and octadecyl-1,1-dimethylpiperidin-1-ium-4-yl phosphate (OPP) were the most efficient vesicles for transcellular transport resulting in 808 +/- 30 pmol calcein/cm(2) in the basal medium (28.1% of total liposomal marker added). Transcytosis was positively correlated with membrane fluidity in the outer part of the bilayer, as electron paramagnetic resonance measurements revealed. We expect that an increase in membrane fluidity of vesicles should also improve the restricted transport of hydrophilic drugs across the blood-brain barrier.
本研究旨在探讨脂质体膜性质对体外紧密连接的 MDCK 细胞屏障细胞摄取和转胞吞作用的影响。通过脂质体薄膜水化/挤压法制备了超过 25 种小囊泡,以生成小单层囊泡。将荧光标记物 calcein 包封以模拟亲水性药物转运。MDCK 细胞对脂质体的摄取似乎是由不同的机制介导的。它主要取决于膜流动性和囊泡电荷。带正电荷的脂质体 L2(325 ± 3 pmol/孔)和膜中含有辅助脂质二油酰基磷脂酰乙醇胺(DOPE)的脂质体 L3(216 ± 42 pmol/孔)被摄取最多。选择的脂质体用于测试其在 MDCK 单层上的转胞吞转运。含有等摩尔 DOPE 和十八烷基-1,1-二甲基哌啶-1-基-4-基磷酸酯(OPP)的脂质体 L4 是用于细胞间转运的最有效的囊泡,导致基础培养基中 calcein 的量为 808 ± 30 pmol/cm²(加入的总脂质体标记物的 28.1%)。转胞吞作用与双层外层的膜流动性呈正相关,如电子顺磁共振测量所示。我们预计,囊泡膜流动性的增加也应该改善亲水性药物在血脑屏障中的受限转运。